1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow Surveillance: new trials by email Literature Review of Surveillance trials Research Report on Surveillance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial Adagrasib, Anti-PD-L1 Monoclonal Antibody, Anti-PD1 Monoclonal Antibody - Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 | Phase 2 | Recruiting | City of Hope Medical Center | 535 | 2026-05-01 | 2026-10-16 |
| Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Gastric Cancer Surveillance, Adjuvant Chemotherapy - Gastric Cancer | Phase 2 | Not yet recruiting | Nizhny Novgorod Regional Clinical Oncology Center | 228 | 2025-04-15 | 2025-04-24 |
| Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer Surveillance, Salvage treatment - Prostate Cancer | Phase 2 | Completed | University Hospital, Ghent | 62 | 2012-08-01 | 2023-09-05 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Prostatic Neoplasms (1) · Stomach Neoplasms (1)
City of Hope Medical Center (1) · Nizhny Novgorod Regional Clinical Oncology Center (1) · University Hospital, Ghent (1)
Belgium (1) · United States (1)
Gert De Meerleer, PhD, MD (1) · Ravi Salgia, MD (1) · Sergey Gamayunov, DMS (1)
PMID 25223986, PMID 25963190, PMID 29240541, PMID 36001857
P30CA033572 (1)